Patients with cancer rarely make clinically inappropriate demands
the ONA take:
According to a new study published in the journal JAMA Oncology, researchers from Abramson Cancer Center and the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania, have found that patients rarely push for unnecessary tests and treatments despite physicians' claims that high medical costs are due to patient demands.
For the study, researchers analyzed over 5,000 patient-clinician encounters and found that 440 (8.7%) of those included a patient request or demand for a particular medical medical intervention. Of those, clinicians complied with 365 of the demands after deeming them clinically appropriate.
Of the 50 demands that were not clinically appropriate, clinicians only complied with seven demands. Results showed that 49.1% of demands were for imaging studies, 15.5% for palliative care interventions, 13.6% for laboratory tests, 5.2% for genetic tests, 3.6% for chemotherapy, and less than 1% for proton beam therapy.
In addition, researchers found that patients who had worse relationships with their clinicians and those actively receiving therapy were more likely to make requests or demands.
The findings suggest that patients demands are low and cannot be a key factor of increasing healthcare costs.
Patients rarely push for unnecessary tests and treatments despite physicians' claims that high medical costs are due to patient demands.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|